Cargando…

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply

Detalles Bibliográficos
Autores principales:	Esen, Idil, Jiemy, William F, van Sleen, Yannick, Reitsema, Rosanne D, Bijzet, Johan, de Jong, Daniel M, Nienhuis, Pieter H, Slart, Riemer H J A, Heeringa, Peter, Boots, Annemieke M H, Brouwer, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Published Online Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258531/ https://www.ncbi.nlm.nih.gov/pubmed/35166769 http://dx.doi.org/10.1093/rheumatology/keac093

Ejemplares similares

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
por: Esen, Idil, et al.
Publicado: (2021)

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Esen, Idil, et al.
Publicado: (2021)

Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients
por: van Nieuwland, Marieke, et al.
Publicado: (2023)

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
por: van der Geest, Kornelis S. M., et al.
Publicado: (2022)

Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8(+) T cells in giant cell arteritis
por: Reitsema, Rosanne D, et al.
Publicado: (2022)

Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021)

Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply
por: Stamatis, Pavlos, et al.
Publicado: (2021)

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort
por: Esen, Idil, et al.
Publicado: (2023)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis
por: van Sleen, Yannick, et al.
Publicado: (2021)

Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis
por: van Sleen, Yannick, et al.
Publicado: (2019)

Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020)

Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis
por: van Sleen, Yannick, et al.
Publicado: (2017)

Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
por: Jiemy, William F, et al.
Publicado: (2020)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

DWI scalp dot sign: superficial temporal artery restricted diffusion in giant cell arteritis
por: Taylor, Eleanor, et al.
Publicado: (2022)

Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA
por: Hid Cadena, Rebeca, et al.
Publicado: (2019)

Comment on: Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Reply
por: Pego-Reigosa, José M, et al.
Publicado: (2021)

Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2022)

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?
por: Reitsema, Rosanne D., et al.
Publicado: (2021)

Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2019)

Effect of age and sex on immune checkpoint expression and kinetics in human T cells
por: Reitsema, Rosanne D., et al.
Publicado: (2020)

Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Reply to the Author
por: Mpoza, Edward, et al.
Publicado: (2020)

First case of pyrin-associated autoinflammation with neutrophilic dermatosis complicated by amyloidosis
por: Kiyota, Masatomo, et al.
Publicado: (2020)

A case of antisynthetase syndrome with thrombotic thrombocytopenic purpura
por: Goreshnik, Ashley, et al.
Publicado: (2020)

Two Independent Hematological malignancies in a B-Cell Deficient Good Syndrome Patient
por: Koning, Marvyn T, et al.
Publicado: (2020)

A 72-year-old man with life-threatening dyspnoea due to a neck mass of unexpected origin
por: Schubert, Nick M.A., et al.
Publicado: (2021)

JAK inhibition for treatment of psoriatic arthritis in Down syndrome
por: Pham, Andrew T., et al.
Publicado: (2021)

Strawberry carina as a presentation of anti-neutrophil cytoplasm antibody–associated vasculitis
por: Chapman, Gavin B, et al.
Publicado: (2021)

Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?
por: Khan, Sujoy
Publicado: (2021)

Vitamin D-resistant osteomalacia after 10 years of haemodialysis in a patient with rheumatoid arthritis
por: Hatano, Masaki, et al.
Publicado: (2021)

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
por: Suruki, Robert Y, et al.
Publicado: (2022)

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
por: Teles, Mayan S, et al.
Publicado: (2022)

Comment on: The neglected and untreated pains of CRMO and SAPHO syndrome
por: Leerling, Anne T, et al.
Publicado: (2022)

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
por: Schreiber, Karen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sh43bcvo77v3h64u81uigei0k6